Liniment Pharma Private Limited - Company Profile

It is a pharma private limited company based in Jaipur, Rajasthan, India, established in 2018.
2018 Jaipur, Rajasthan, India Active
Last Updated:
About Liniment Pharma Private Limited

Liniment Pharma Private Limited, a active private limited company, was established on 26 February 2018 in Jaipur, Rajasthan, India. Engaging in drug formulation & development within the transport and storage sector, it holds CIN: U24304RJ2018PTC060344. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.24 M.

Employing 10 professional, Its leadership includes Rohit Bafna (Director), Aastha Dusad (Director). Past directors included Shakti Singh Rao, Jaydeep Dosi, Rahul Gautam. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.-38,Shankar Colony Naya Kheda, Ambabari, Jaipur, Rajasthan, 302039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304RJ2018PTC060344

  • Registration Number

    060344

  • Incorporation Date

    26 February 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.24 M

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.24 M
  • Company Age 7 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 79.16%
  • Profit Growth **** -45.19%
  • Ebitda **** -43.37%
  • Net Worth 593.58%
  • Total Assets **** 78.29%
Company report

Liniment Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Liniment Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Liniment Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Rohit Bafna Director 26 Feb 2018 Current
Aastha Dusad Director 26 Feb 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 25 May 2018 Past
Pramod Abcsdd Director 25 May 2018 Past
Pramod Abcsdd Additional Director 13 Feb 2020 Past
Pramod Abcsdd Additional Director 15 Nov 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Liniment Pharma.

Liniment Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 79.16% increase. The company also saw a substantial fall in profitability, with a 45.19% decrease in profit. The company's net worth Soared by an impressive increase of 593.58%.

Liniment Pharma revenue growth over time
Liniment Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
79.16%
*******
*******
*******
*******
Revenue from Operations
*******
85.03%
*******
*******
*******
*******
Total Assets
*******
78.29%
*******
*******
*******
*******
Profit or Loss
*******
-45.19%
*******
*******
*******
*******
Net Worth
*******
593.58%
*******
*******
*******
*******
EBITDA
*******
-43.37%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Liniment Pharma?

In 2022, Liniment Pharma had a promoter holding of 73.97% and a public holding of 26.03%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Liniment Pharma?

Liniment Pharma has a workforce of 10 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Liniment Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Liniment Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Liniment Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Liniment Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Liniment Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur. was documented.

  • Director Appointment

    Rohit Bafna was appointed as a Director was appointed as a Director on 26 Feb 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.

  • Director Appointment

    The activity Aastha Dusad was appointed as a Director was appointed as a Director on 26 Feb 2018 & has been associated with this company since 7 years 11 months . was completed.

  • Company Incorporation

    Progress on Liniment Pharma Private Limited was registered on 26 Feb 2018 with Roc Jaipur & aged 7 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Liniment Pharma Private Limited?

The CIN of Liniment Pharma Private Limited is U24304RJ2018PTC060344.

Where is Liniment Pharma Private Limited headquartered?

Liniment Pharma Private Limited is headquartered at Plot No.-38,Shankar Colony Naya Kheda, Ambabari, Jaipur, Rajasthan, 302039.

When was Liniment Pharma Private Limited incorporated?

Liniment Pharma Private Limited was incorporated on 26 February 2018.

Who are the current directors of Liniment Pharma Private Limited?

The current directors of Liniment Pharma Private Limited are

What is the primary industry of Liniment Pharma Private Limited?

The primary industry of Liniment Pharma Private Limited is Transport And Storage.

Is Liniment Pharma Private Limited a listed company?

Liniment Pharma Private Limited is unlisted.

What is the capital structure of Liniment Pharma Private Limited?

The authorized capital of Liniment Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.24 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available